The layoffs will affect employees in research, clinical development and administrative roles.
In addition, Dynavac CEO Eddie Gray will step down from his role Aug. 1 as part of the restructuring effort.
The plan comes as the biotech works to shift its focus and resources from immuno-oncology and to vaccines, including its first commercial product, which is a hepatitis B vaccine.
Read the full report here.
More articles on pharmacy:
How hospitals can better align the pharmacy to achieve its strategic goals
Google sister-company Verily partners with big pharma for clinical trials
Merck’s Keytruda fails late-stage trial as standalone treatment for breast cancer
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
